Clearview Wealth Advisors LLC Organon & Co. Transaction History

Clearview Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	SELL	$21.42 - $32.08 $85 - $128	-4 Reduced 16.0%	21 $0
Q4 2022 Jan 31, 2023	SELL	$23.31 - $28.61 $46 - $57	-2 Reduced 7.41%	25 $0
Q1 2022 Apr 29, 2022	SELL	$30.45 - $39.36 $791 - $1,023	-26 Reduced 49.06%	27 $1,000
Q4 2021 Feb 02, 2022	SELL	$28.67 - $37.13 $1,748 - $2,264	-61 Reduced 53.51%	53 $2,000
Q3 2021 Nov 02, 2021	BUY	$28.63 - $35.64 $3,263 - $4,062	114 New	114 $4,000

793

204M

1.71M

870K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.72B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.